Powered by Ziptron technology, the electric SUV for the personal segment comes with a range of 312 km on a single charge and a high voltage system, fast charging capability, extended battery life and class leading safety features. Besides, it has 35 connected car features as well. The Nexon EV will be available in three trim levels across 60 authorised dealerships in 22 cities, the company said at the launch.
The novel mRNA vaccine candidate, HGCO19, is supported with seed grant under the Ind-CEPI mission of the Department of Biotechnology. The mRNA vaccines do not use the conventional model to produce immune response. Instead, they carry molecular instructions to make the protein in the body through a synthetic RNA of the virus.
According to medical practitioners, the treatment is especially useful in controlling disease among those who have not received the vaccine or got only one shot and also the high-risk contacts of a patient.
The National Investigation Agency Wednesday registered a case under the anti-terror Unlawful Activities (Prevention) Act in connection with the 'heinous murder' of a tailor in Rajasthan's Udaipur by two people who, the agency said, wanted to 'strike terror among the masses across the country'.
As India prepares to launch its vaccine drive on January 16, here is a look at the options:
Reliance has a 24 per cent conversion rate of 'oil-to-chemicals' at present and may be targeting 70 per cent conversion.
A steady decline in new COVID-19 cases has been recorded in India for the last 20 days, with 24 states witnessing a dip in active cases since the last week, the Union health ministry said.
What will it take for Tesla to plug and play in India? Sector pundits say it's a mix of strategy, getting the price right, timing, the right talent, and above all, patience.
India's electric mobility goal, which has so far been riding on two wheels, is all set to graduate to four wheels. At least, the journey has begun. Hyundai Motor India said it would invest Rs 4,000 crore till 2028 to launch half-a-dozen electric vehicles (EVs) in India. It would eventually straddle premium and mass segments. The first of these - the electrified version of an internal combustion engine (ICE)-powered model - will go on sale as early as next year.
The new vaccine candidate, DIOS-CoVax2, uses banks of genetic sequences of all known coronaviruses, including those from bats, believed to be the natural hosts of many relatives of human coronaviruses.
As a tech services company, Ola has never been in hardcore manufacturing. And unlike in ride hailing, which is a two-player market (Uber is the only other competitor), in two-wheelers it faces many entrenched players. But most of all, rivals say Ola's targets are out of sync with most, even ambitious, projections.
A tug of war was witnessed in a Delhi court between the National Investigation Agency and the Special Cell of Delhi Police for seeking the custody of top Indian Mujahideen operatives Tehseen Akhtar and Zia-ur-Rehman alias Waqas.
The national budget 2019-20 had an outlay of Rs 10,000 crore for Phase-II of the Faster Adoption and Manufacturing of Hybrid and Electric Vehicles scheme to boost electric mobility and increase the number of EVs in commercial fleets.
If we are to realise the full potential of biologics' ability to improve people's health, it is essential to encourage public policy and support R&D.
India is one of the largest manufacturers of pharmaceutical products in the world with the annual production valued at over Rs 2 lakh crore.
The domestic solar equipment industry is grappling with tough market conditions, mainly on account of cheaper imports from China.
US-India Business Council President Nisha Biswal believes once the economic activity and demand resumes, India could hold the potential for diversification of supply chains and manufacturing.
Vaccine manufacturer Serum Institute of India on Friday said Rabivax, the country's first Human Diploid Cell rabies vaccine launched by the company recently, would trigger the company's market share in this segment to about 30 per cent from the curre
The approval by the Drugs Controller General of India (DCGI) was given on the basis of recommendations submitted by a COVID-19 subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).
The CoWIN portal will be made available in Hindi and 14 regional languages by next week, while 17 more laboratories will be added to the INSACOG network to monitor the variants of COVID-19, the health ministry said on Monday.
The International Telecommunication Union has announced the success of its expert team in finalising an energy efficient standard mobile charger for all the cell phones in the world, irrespective of which company has manufactured them.
The Prime Minister will be releasing separate brochures for these sectors along with a general brochure.
Those who have recovered from COVID-19 respond faster to the Covishield vaccine and reach high antibody levels, says a study, leading to hopes that they may not need a second dose and therefore help widen India's corona immunisation cover.
.jpg)
India has been pursuing measures that discriminate against overseas businesses, says US Congressman Erik Paulsen.
Recently, Suzuki Motor Corp (SMC) in an investor presentation expressed strong intent to enter the electric vehicle (EV) space. This is part of a larger strategy the Hamamatsu-based firm has drawn up in developing electrification of technologies as it seeks to achieve carbon neutrality. The significance of this presentation is that it marked the first time that the Japanese carmaker spelt out its EV strategy with well-defined timelines. SMC plans to develop electrification technologies by 2025, fully implement them in products from the same year, and make a full-scale quantitative increase from 2030.
'The majority of transmission will be via people who are within two metres of one another.' 'The closer you are, the more likely that you'll be infected.'
The Drugs Control General of India has permitted emergency use of Covid vaccine Sputnik V with certain conditions, clearing the way for a third vaccine in addition to Covishield and Covaxin. Besides, the government on Tuesday also fast-tracked emergency approval for other jabs. Here is what the vaccines are all about:
The operators say that the move to have an India-specific standard will raise the costs not only of telecom networks but of chipsets for mobile devices because they will have to be made for the local market and, as such, will not enjoy global economies of scale.
Kolkata-based Kirti solar Ltd has decided to be a cog in the wheel of solar power generation in our country. In a conversation with rediff.com, Dhiraj Bhagchandka, managing director of the company, speaks about his company and how it plans to bring light to Indian villages.
Pfizer can show the FDA approval to the Indian regulator and present a case that based on whatever data submitted, the US regulator has granted a full marketing nod, says Sohini Das.
The company planning to have a larger push to small car even as sales continue to remain subdued.
According to software company Mavernir, the new virtualised networks would lead to a saving of 40 per cent in capex and 34 per cent in terms of lower operations cost for operators.
The aircraft has to fly through five consecutive days.
The Delhi Police on Friday filed a charge sheet in a court against suspected top Indian Mujahideen operatives Tehsin Akhtar, Zia-Ur-Rahman and three others for allegedly setting up an illegal arms factory in the national capital from where a huge quantity of arms and ammunition were recovered.
The Congress on Monday demanded an independent probe into the issue involving alleged phone tapping of prominent personalities including journalists in India using Israeli Pegasus spyware.
Eyeing to become India's largest player in 2020 Adani Group plans to invest 70 per cent of its capital expenditure in clean energy and energy efficient systems.
Core sectors like manufacturing were the second largest recruiters at the newer IITs.
The Telecom Regulatory Authority of India (Trai) has directed the Cellular Operators Association of India (COAI) to make a presentation detailing the pros and cons of the controversial Indian 5G standard, also known as 5Gi, which the government has been pushing for. The move comes after serious differences emerged among telcos with regard to the technology's efficacy and implementation.
The phase 3 trial findings indicate that Covaxin induces a robust antibody response with no severe vaccine-related adverse events or deaths reported among the trial participants, the authors of the study said.
Industry estimates suggest that the extent of value addition in the handset space remains at a mere 10 per cent. That effectively means, value-wise 90 per cent of all components used in making a handset continues to be imported.
